Metanephric adenoma and solid variant of papillary renal cell carcinoma: Common and distinctive features

Histopathology

Volumn 62, Issue 6, 2013, Pages 941-953

  Mantoan Padilha, Mariana ^a,b   Billis, Athanase ^b   Allende, Daniela ^c   Zhou, Ming ^d   Magi Galluzzi, Cristina ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c DEPARTMENT OF COLORECTAL SURGERY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Differential diagnosis; Immunohistochemistry; Metanephric adenoma; Solid variant of papillary renal cell carcinoma

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CD57 ANTIGEN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; PROTEIN S 100; WT1 PROTEIN;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CALCINOSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DIFFERENTIAL DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METANEPHRIC ADENOMA; MICROSCOPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSAMMOMA BODY; SCHOOL CHILD; SOLID PAPILLARY RENAL CELL CARCINOMA;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD57; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUCIN-1; RACEMASES AND EPIMERASES; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS; YOUNG ADULT;

EID: 84876804074     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12106     Document Type: Article

References (50)

1. Amin MB, Amin MB, Tamboli P et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 2002; 26; 281-291.
2. Grignon DJ, Eble JN. Papillary and metanephric adenomas of the kidney. Semin. Diagn. Pathol. 1998; 15; 41-53.
3. Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J. Urol. 2006; 176; 2391-2395; discussion 5-6.
4. Davis CJ Jr. Barton JH, Sesterhenn IA, Mostofi FK. Metanephric adenoma. Clinicopathological study of fifty patients. Am. J. Surg. Pathol. 1995; 19; 1101-1114.
5. Algaba F, Akaza H, Lopez-Beltran A et al. Current pathology keys of renal cell carcinoma. Eur. Urol. 2011; 60; 634-643.
6. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am. J. Surg. Pathol. 1997; 21; 621-635.
7. Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR. Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am. J. Surg. Pathol. 1997; 21; 1203-1209.
8. Argani P, Netto GJ, Parwani AV. Papillary renal cell carcinoma with low-grade spindle cell foci: a mimic of mucinous tubular and spindle cell carcinoma. Am. J. Surg. Pathol. 2008; 32; 1353-1359.
9. Jones EC, Pins M, Dickersin GR, Young RH. Metanephric adenoma of the kidney. A clinicopathological, immunohistochemical, flow cytometric, cytogenetic, and electron microscopic study of seven cases. Am. J. Surg. Pathol. 1995; 19; 615-626.
10. Delahunt B. Advances and controversies in grading and staging of renal cell carcinoma. Mod. Pathol. 2009; 22(Suppl. 2); S24-S36.
11. Edge SBBD, Comptom CC, Fritz AG, Greene FL, Trotti A eds. AJCC Cancer Staging, 7th edn. New York: Springer-Verlag, 2010; 525e38.
12. Zhou M, Yang XJ, Lopez JI et al. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am. J. Surg. Pathol. 2009; 33; 1840-1849.
13. Amie F, Andre D, Foulet RogeA, Goura E, Chautard D, Colombel P. [Bilateral renal metanephric adenoma]. Prog. Urol. 2004; 14; 534-537; discussion 7.
14. Azabdaftari G, Alroy J, Banner BF, Ucci A, Bhan I, Cheville JC. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms. Pathol. Res. Pract. 2008; 204; 719-723.
15. Brown JA, Anderl KL, Borell TJ, Qian JQ, Bostwick DG, Jenkins RB. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. J. Urol. 1997; 158; 370-374.
16. Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod. Pathol. 2003a; 16; 1060-1063.
17. Burger M, Junker K, Denzinger S et al. Metanephric adenoma of the kidney: a clinicopathological and molecular study of two cases. J. Clin. Pathol. 2007; 60; 832-833.
18. Choueiri TK, Cheville J, Palescandolo E et al. BRAF mutations in metanephric adenoma of the kidney. Eur. Urol. 2012; 62; 917-922.
19. Hes O, Michal M, Perez-Montiel DM et al. [Metanephric adenoma. 11 case reports and detection of collagen spherules in one tumor]. Cesk. Patol. 2002; 38; 101-106.
20. Imamoto T, Furuya Y, Ueda T, Ito H. Metanephric adenoma of the kidney. Int. J. Urol. 1999; 6; 200-202.
21. Kohashi K, Oda Y, Nakamori M et al. Multifocal metanephric adenoma in childhood. Pathol. Int. 2009; 59; 49-52.
22. Liniger B, Wolf RW, Fleischmann A, Kluwe W. Local resection of metanephric adenoma with kidney preservation. J. Pediatr. Surg. 2009; 44; E21-E23.
23. Mei H, Zheng L, Zhou C, Tong Q. Metanephric adenoma in a 2-year-old child: case report and immunohistochemical observations. J. Pediatr. Hematol. Oncol. 2010; 32; 489-493.
24. Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison. Am. J. Surg. Pathol. 2001; 25; 1290-1296.
25. Nagashima Y, Arai N, Tanaka Y et al. Two cases of a renal epithelial tumour resembling immature nephron. Virchows Arch. A. Pathol. Anat. Histopathol. 1991; 418; 77-81.
26. Navarro O, Conolly B, Taylor G, Bagli DJ. Metanephric adenoma of the kidney: a case report. Pediatr. Radiol. 1999; 29; 100-103.
27. Olgac S, Hutchinson B, Tickoo SK, Reuter VE. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod. Pathol. 2006; 19; 218-224.
28. Pan CC, Epstein JI. Detection of chromosome copy number alterations in metanephric adenomas by array comparative genomic hybridization. Mod. Pathol. 2010; 23; 1634-1640.
29. Paner GP, Turk TM, Clark JI, Lindgren V, Picken MM. Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Arch. Pathol. Lab. Med. 2005; 129; 1317-1321.
30. Rakheja D, Lian F, Tomlinson GE, Ewalt DH, Schultz RA, Margraf LR. Renal metanephric adenoma with previously unreported cytogenetic abnormalities: case report and review of the literature. Pediatr. Dev. Pathol. 2005; 8; 218-223.
31. Renshaw AA, Freyer DR, Hammers YA. Metastatic metanephric adenoma in a child. Am. J. Surg. Pathol. 2000; 24; 570-574.
32. Schmelz HU, Stoschek M, Schwerer M et al. Metanephric adenoma of the kidney: case report and review of the literature. Int. Urol. Nephrol. 2005; 37; 213-217.
33. Szponar A, Yusenko MV, Kovacs G. High-resolution array CGH of metanephric adenomas: lack of DNA copy number changes. Histopathology 2010; 56; 212-216.
34. Tsuji M, Murakami Y, Kanayama H, Sano T, Kagawa S. A case of renal metanephric adenoma: histologic, immunohistochemical and cytogenetic analyses. Int. J. Urol. 1999; 6; 203-207.
35. Zafar N, Spencer D, Berry AD III. Embryonal adenoma of the kidney: a report of two cases. Diagn. Cytopathol. 1997; 16; 42-46.
36. Ngan KW, Ng KF, Chuang CK. Solid variant of papillary renal cell carcinoma. Chang Gung Med. J. 2001; 24; 582-586.
37. Cantley R, Gattuso P, Cimbaluk D. Solid variant of papillary renal cell carcinoma with spindle cell and tubular components. Arch. Pathol. Lab. Med. 2010; 134; 1210-1214.
38. Pins MR, Jones EC, Martul EV, Kamat BR, Umlas J, Renshaw AA. Metanephric adenoma-like tumors of the kidney: report of 3 malignancies with emphasis on discriminating features. Arch. Pathol. Lab. Med. 1999; 123; 415-420.
39. Portugal R, Barroca H. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour. Cytopathology 2008; 19; 80-85.
40. Jain M, Rastogi A, Gupta RK. Atypical metanephric adenoma - a case report and review of literature. Int. Urol. Nephrol. 2007; 39; 123-127.
41. Zhang LJ, Yang GF, Shen W, Lu GM. CT and ultrasound findings of metanephric adenoma: a report of two cases and literature review. Br. J. Radiol. 2011; 84; e51-e54.
42. Obulareddy SJ, Xin J, Truskinovsky AM, Anderson JK, Franklin MJ, Dudek AZ. Metanephric adenoma of the kidney: an unusual diagnostic challenge. Rare Tumors 2010; 2; e38.
43. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am. J. Surg. Pathol. 1995; 19; 842-849.
44. Bisceglia M, Ragazzi M, Galliani CA, Lastilla G, Rosai J. TTF-1 expression in nephroblastoma. Am. J. Surg. Pathol. 2009; 33; 454-461.
45. Ban S, Yoshii S, Tsuruta A et al. Metanephric adenoma of the kidney: ultrastructural, immunohistochemical and lectin histochemical studies. Pathol. Int. 1996; 46; 661-666.
46. Brunelli M, Eble JN, Zhang S, Martignoni G, Cheng L. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Mod. Pathol. 2003b; 16; 1053-1059.
47. Kattar MM, Grignon DJ, Wallis T et al. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma. Mod. Pathol. 1997; 10; 1143-1150.
48. Gatalica Z, Grujic S, Kovatich A, Petersen RO. Metanephric adenoma: histology, immunophenotype, cytogenetics, ultrastructure. Mod. Pathol. 1996; 9; 329-333.
49. Granter SR, Fletcher JA, Renshaw AA. Cytologic and cytogenetic analysis of metanephric adenoma of the kidney: a report of two cases. Am. J. Clin. Pathol. 1997; 108; 544-549.
50. Hes O, Sima R, Nemcova J et al. End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue. Virchows Arch. 2008; 453; 313-319.